AKT1 and lung adenocarcinoma: Additionally, it has been proven that SERINC2 may affect cell proliferation and migration in lung adenocarcinoma cells through the PI3K/AKT pathway [22], and SERINC2 cis-activated by long non-coding enhancer RNA may regulate tumor lipid metabolism to affect leukemia progression in MLL rearrangement leukemia [23].